9-hydroxy-10,12-octadecadienoic acid has been researched along with malondialdehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banka, CL; Brand, K; Curtiss, LK; Santoro, D; Solan, J; Terkeltaub, R | 1 |
| Esterbauer, H; Exner, M; Gmeiner, BM; Hermann, M; Kapiotis, S; Laggner, H; Muellner, MK; Schreier, SM | 1 |
| Habazi, D; Han, J; Mohan, C; Saxena, R; Wu, T; Ye, Y; Zhang, T | 1 |
3 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and malondialdehyde
| Article | Year |
|---|---|
Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity.
Topics: Acetylation; Chemotaxis, Leukocyte; Humans; Interleukin-1; Interleukin-8; Leukemia, Myeloid; Linoleic Acids; Linoleic Acids, Conjugated; Lipoproteins, LDL; Malondialdehyde; Monocytes; Oxidation-Reduction; Phospholipases A; Phospholipases A2; T-Lymphocytes; Thiobarbituric Acid Reactive Substances; Tumor Cells, Cultured | 1994 |
Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL.
Topics: Analysis of Variance; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; Hydrogen Sulfide; Linoleic Acids; Linoleic Acids, Conjugated; Lipid Peroxides; Lipoproteins, LDL; Malondialdehyde; Reverse Transcriptase Polymerase Chain Reaction; Thiobarbituric Acid Reactive Substances; Time Factors | 2009 |
Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
Topics: Autoantibodies; Case-Control Studies; Complement C3; Complement C4; DNA; Humans; Immunoglobulin G; Immunoglobulin M; Linoleic Acids; Linoleic Acids, Conjugated; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Phospholipid Ethers; Severity of Illness Index | 2019 |